Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Semaglutide's Specific Approval for Weight Loss In recent media coverage, semaglutide has gained recognition for its specific approval for weight loss, distinguishing it from other medications
However, during follow-up beyond six months, semaglutide use was associated with a significantly lower risk than liraglutide use (HR 0.80
FDA-Approved Indications Tirzepatide is currently approved by the FDA to treat type 2 diabetes, with ongoing studies to expand its approval for weight-loss purposes
(PubMed) Shulpekova Y, Nechaev V, Kardasheva S, et al
This is a legitimate basis for clinical use but a different evidence tier than RCT data
Expanding Pipeline The GLP-1 pipeline is rich with new indications for existing FDA approved drugs as well as new market entrants
US$ 20.96
US$ 22.24
US$ 20.71
US$ 20.10
US$ 26.57
US$ 27.81
US$ 21.34
